Innovative Medicines Initiative - IMI 2, upcoming calls

|In Evidence|10 December 2015

IMI (Innovative Medicine Initiative) 2 is the world's biggest public-private partnership (PPP) in the life sciences. Through the IMI 2 programme, it has a 3,3 billion of euros budget for the period 2014-2024.

The indicative topics under consideration for inclusion in the first call are:        

  • Validation of translational imaging methods in drug safety assessment (TRISTAN)
  • Identification of drugable targets modulating misfolded proteins in major neurodegenerative diseases
  • Pathological neuron-glia interactions in neuropathic pain
To read this content please subscribe or upgrade your Membership.
Individual
€ 0 / month
News free, programmes and events
Call for proposals (Individuals)
Calls monitoring with email alerts: 1 max
International
€ 9,99 / month*
News free, programmes and events
Anticipations, Insights, Focus, Summaries, Projects, Docs summary
Calls for proposals and tenders: UE + extra UE
Calls updates
Calls monitoring with email alerts: 5 max
Online support : 3 per year
10% discount on training courses
Affiliated consultant provision

*VAT excluded - Promotional prices - Single user access